AEON — Aeon Biopharma Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Aeon Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 5.13 | 9.75 | 5.16 | 0.013 | 3.01 |
| Prepaid Expenses | |||||
| Total Current Assets | 5.15 | 9.84 | 6.22 | 1.59 | 3.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.922 | 0.906 | 0.594 | 1.52 | 1.21 |
| Other Long Term Assets | |||||
| Total Assets | 6.44 | 10.8 | 6.84 | 3.14 | 5.56 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.8 | 82.6 | 13 | 14.1 | 6.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 103 | 160 | 160 | 31.7 | 60.6 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -97 | -150 | -153 | -28.6 | -55 |
| Total Liabilities & Shareholders' Equity | 6.44 | 10.8 | 6.84 | 3.14 | 5.56 |
| Total Common Shares Outstanding |